Instillagel (Chlorhexidine Gluconate, Methyl Parahydroxybenzoate, Propyl Parahydroxybenzoate, Lidocaine Hydrochlo)

Chlorhexidine disrupts bacterial cell membranes by binding to phospholipids, causing leakage of intracellular components and cell death. This broad‑spectrum action reduces the number of bacteria on mucosal surfaces, while lidocaine blocks sodium channels to produce a reversible loss of sensation.

The dose of Instillagel is determined by the prescribing clinician based on the specific procedure and anatomical site. The product is supplied as a gel that is applied in a thin layer to the targeted mucosa, and the amount used is guided by professional medical judgment.

Safety data for Instillagel in pregnancy and lactation are limited. It should be used only if clearly needed and after a risk‑benefit assessment by the healthcare provider. Women who are pregnant or breastfeeding should discuss potential risks with their clinician before use.

To order Instillagel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Instillagel combines chlorhexidine, a well‑established antiseptic, with lidocaine for local anaesthesia, offering both antimicrobial action and pain relief. Many alternative gels contain only antiseptic agents without anaesthetic, so Instillagel may provide added comfort during procedures, though choice depends on clinical needs and patient tolerance.

Instillagel should be stored at room temperature, below 25 °C, in its original packaging. Protect the gel from moisture, direct sunlight and extreme temperatures. Keep the container tightly closed when not in use to maintain product stability.

Instillagel is applied topically to the targeted mucosal surface. A thin layer is spread using a sterile applicator or gloved finger, covering the area to be treated. The gel is left in place for the duration recommended by the clinician, after which it may be rinsed or left to dissolve naturally.

The most serious risks include allergic reactions such as anaphylaxis, severe mucosal irritation, and rare systemic toxicity from lidocaine. Users should be monitored for signs of rash, swelling, difficulty breathing, or persistent ulceration, and medical attention should be sought immediately if these occur.

Instillagel should not be used by individuals with known hypersensitivity to chlorhexidine, lidocaine, methylparaben, or propylparaben. It is also contraindicated on extensive open wounds, in the ear canal, or in patients where local anaesthesia is contraindicated without prior medical evaluation.